Abstract：Objective: To explore the safety and efficacy of transurethral columnar balloon dilation of prostate (TUCBDP) under ultrasound guidance for treatment of benign prostatic hyperplasia (BPH). Methods: The clinical data and follow-up data of 179 cases of BPH were retrospectively analyzed in our hospital between February 2013 and December 2016. Fifty cases of BPH were treated by TUCBDP, 54 cases of BPH were treated by TUCBDP under ultrasound guidance, and 75 cases of BPH were treated by transurethral resection of the prostate (TURP). Results: The operations in all groups were successfully performed. The operating time in TUCBDP group and TUCBDP under ultrasound guidance group was (14.6±3.1) min and (15.1±3.6) min respectively, which was shorter than that in TURP group [(54.0±9.8) min]. The intraoperative blood loss in TUCBDP group and TUCBDP under ultrasound guidance group was (24.2±4.8) and (26.0±5.2) mL respectively, which was less than that in TURP group [(140.5±27.4) mL]. There was no significant difference in the length of hospital stay among the three groups. Twelve months later, the international prostate symptom score (IPSS), maximum urinary flow rate and residual urine volume in the three groups were improved significantly as compared with those preoperation (P<0.05). The incidence of urinary incontinence after TUCBDP under ultrasound guidance was lower than that after TUCBDP. Conclusions: TUCBDP under ultrasound guidance was safe and efficient in the treatment of benign prostatic hyperplasia, the operation time was shorter, and the incidence of complications was lower. It had equal curative effect compared with TURP. It was suitable for patients with benign prostatic hyperplasia.
[1] 郭应禄,周利群,孙颖浩.泌尿外科内镜诊断治疗学.2版.北京:北京大学医学出版社,2016:91-95. [2] 李慧.高龄前列腺增生患者手术治疗.现代仪器与医疗,2016,22(2):119-121. [3] 孙超,薛向东,汪柏林,等.良性前列腺增生与代谢综合征的相关性研究.中国医科大学学报,2015,44(1):15-19. [4] Parsons JK, Mougey J, Lambert L, et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int, 2009,104(1):63-68. [5] Bhojani N, Gandaglia G, Sood A, et al. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons National surgical quality improvement program. J Endourol, 2014,28(7):831-840. [6] Yip SK, Chan NH, Chiu P, et al. A randomized controlled trial comparing the efficacy of hybrid bipolar transurethral vaporization and resection of the prostate with bipolar transurethral resection of the prostate. J Endourol, 2011,25(12):1889-1894. [7] 黄卫国,刘锋,张裕.柱状水囊扩开术治疗高危高龄良性前列腺增生.江苏医药,2012,38(23):2868-2869. [8] 姜汉胜,阎乐法,王群,等.四腔高压气囊前列腺扩裂导管的研制及应用.中华泌尿外科杂志,1998,19(3):154. [9] 刘加升,马元华,许正国,等.经尿道前列腺扩裂术与电化学治疗前列腺增生致急性尿潴留的疗效比较.中国男科学杂志,2008,22(8):50-52,55. [10] 陆兆祥,梁法政,江墩勤,等.经尿道等离子电切术治疗高龄高危前列腺增生患者的疗效.安徽医学,2016,37(4):438-440. [11] 王焕瑞,许克新,胡浩,等.经尿道前列腺电切术10年变迁.现代泌尿外科杂志,2016,21(4):298-300.
